Treated by Dr. Dasari Keerthi Kumar at Harsha Sai Eye Hospital
Retinopathy of Prematurity (ROP) screening in Nizamabad is a critical eye examination for premature infants to detect abnormal blood vessel development in the retina. This condition primarily affects babies born before 31 weeks of gestation or weighing less than 1500 grams at birth. Early detection through systematic screening can prevent vision loss and blindness in vulnerable newborns. Dr. Dasari Keerthi Kumar at Harsha Sai Eye Hospital provides specialized ROP screening services to ensure timely diagnosis and intervention for premature babies in Nizamabad.
Severe form requiring urgent treatment within 48 hours. Characterized by zone I disease with plus disease, zone I stage 3 without plus disease, or zone II stage 2 or 3 with plus disease. High risk of progression to retinal detachment if left untreated.
Pre-threshold disease requiring close monitoring every 1-2 weeks. Includes zone I stage 1 or 2 without plus disease, or zone II stage 3 without plus disease. May regress spontaneously or progress to Type 1 requiring intervention.
Rapidly progressive severe form occurring in posterior retina with flat neovascularization and plus disease. Previously called Rush disease, it requires immediate treatment as it progresses quickly to stage 5 retinal detachment within days if not treated urgently.
Multiple factors can contribute to the development and progression of this condition.
Retinopathy of Prematurity (ROP) Screening develops gradually. Recognising symptoms early gives you more treatment options.
From conservative to surgical — we always start with the least invasive option first.
A structured, patient-first approach from first visit to full recovery.
Harsha Sai Eye Hospital follows systematic screening guidelines for all premature infants born before 32 weeks gestation or weighing less than 1500 grams. Our team coordinates with neonatology units to ensure timely first examination at 4 weeks postnatal age or 31 weeks postmenstrual age, whichever is later.
Dr. Dasari Keerthi Kumar performs detailed indirect ophthalmoscopy with scleral depression using specialized pediatric equipment. Digital wide-field retinal imaging is utilized to document findings and facilitate telemedicine consultation when needed. Each examination assesses zone, stage, extent, and presence of plus disease for accurate classification.
Based on ROP classification, our team develops customized management plans ranging from continued observation to urgent treatment intervention. For Type 1 ROP, treatment is scheduled within 48 hours using laser photocoagulation or anti-VEGF therapy. We counsel parents thoroughly about treatment options, expected outcomes, and follow-up requirements.
Harsha Sai Eye Hospital provides comprehensive follow-up care extending beyond the neonatal period to monitor for late complications including refractive errors, strabismus, amblyopia, and retinal detachment. Our pediatric ophthalmology services ensure continuous care through childhood with regular vision assessments and early intervention for any developmental concerns.
What to expect at each phase of recovery.
Following laser photocoagulation or anti-VEGF injection, infants are monitored in the neonatal unit for any systemic or ocular complications. Eyes may appear red or swollen for 1-2 days. Follow-up examination is scheduled within one week to assess treatment response and regression of abnormal vessels.
Over 4-12 weeks following treatment, abnormal vessels regress and retinal vascularization stabilizes. Regular examinations every 1-2 weeks initially, then monthly, monitor for complete regression or need for additional treatment. Most treated eyes show favorable anatomical outcomes with maintained retinal attachment.
Even with successful ROP treatment, children require ongoing ophthalmologic care throughout childhood. Annual comprehensive eye examinations monitor for refractive errors (especially myopia), amblyopia, strabismus, glaucoma, and late retinal complications. Early intervention with glasses, patching, or additional procedures optimizes visual outcomes and quality of life.
Timely screening and treatment of Type 1 ROP prevents progression to retinal detachment in over 90% of cases, preserving functional vision for affected infants. Early intervention significantly reduces the risk of bilateral blindness that would otherwise occur in untreated severe ROP.
Successful laser photocoagulation or anti-VEGF therapy achieves complete disease regression with stable retinal attachment throughout childhood in the majority of treated eyes. This anatomical success provides the foundation for useful vision development during critical early years.
Children who receive appropriate ROP screening and timely treatment typically develop sufficient vision for normal developmental milestones including recognition of faces, hand-eye coordination, and mobility. While vision may not be completely normal, functional outcomes support quality of life and independence.
Modern treatment approaches, particularly anti-VEGF therapy which spares peripheral retina, may reduce the severity of high myopia and astigmatism commonly associated with ROP. Regular follow-up allows early detection and correction of refractive errors to prevent amblyopia and optimize visual potential.
Untreated severe ROP progresses to partial or complete retinal detachment within weeks, resulting in permanent severe visual impairment or total blindness. By age 3-6 months, untreated Type 1 ROP typically advances to stage 5 with total retinal detachment, producing irreversible blindness that profoundly impacts child development, education, and lifelong independence. Early bilateral blindness from untreated ROP represents one of the leading preventable causes of childhood blindness worldwide.
All premature infants born before 32 weeks gestational age or with birth weight less than 1500 grams must undergo ROP screening beginning at 4 weeks postnatal age. Infants with unstable clinical courses, prolonged oxygen therapy, or other risk factors between 1500-2000 grams should also be screened. Parents should ensure completion of all scheduled follow-up examinations as disease progression can occur rapidly between screening visits, and timely detection of treatment-requiring ROP is critical to prevent blindness.
Early treatment means more options and better outcomes. Book a consultation to understand your condition and explore the right path forward.
